Quantitative Investment Management, LLC Dynavax Technologies Corp Transaction History

Quantitative Investment Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$7.25 - $10.99 $137,916 - $209,062	-19,023 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$4.57 - $11.18 $86,935 - $212,677	19,023 New	19,023 $186,000
Q4 2020 Feb 16, 2021	SELL	$3.73 - $5.6 $362,059 - $543,575	-97,067 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$4.32 - $11.7 $419,329 - $1.14 Million	97,067 New	97,067 $419,000
Q2 2020 Aug 14, 2020	SELL	$2.94 - $9.1 $38,655 - $119,646	-13,148 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$2.27 - $6.2 $29,845 - $81,517	13,148 New	13,148 $46,000
Q4 2019 Feb 14, 2020	SELL	$3.46 - $6.93 $136,420 - $273,236	-39,428 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$2.69 - $4.85 $281,113 - $506,839	-104,503 Reduced 72.61%	39,428 $140,000
Q2 2019 Aug 14, 2019	BUY	$3.65 - $7.89 $525,348 - $1.14 Million	143,931 New	143,931 $574,000
Q2 2018 Aug 10, 2018	SELL	$15.15 - $20.75 $1.69 Million - $2.31 Million	-111,500 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$14.65 - $19.9 $1.63 Million - $2.22 Million	111,500 New	111,500 $2.21 Million

281

130M

451K

203K

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.66B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

Get notified when there are updates to the investment portfolio of Quantitative Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Quantitative Investment Management, LLC with notifications on news.